Login to Your Account

Aradigm's Inhaled Insulin Falters As More Diabetes Drugs Line Up

By Randall Osborne

Monday, May 10, 2004

The likes of cancer and rheumatoid arthritis might have upstaged diabetes in the biotechnology limelight, but the disease is steadily on the march. More than 12 million Americans have been diagnosed, and the prevalence of the disease has jumped by 30 percent in the past decade. It's the No. 1 cause of adult blindness, kidney failure and amputations - not to mention heart disease.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription